News

NewsJanuary 12, 2021

Allergan Aesthetics Enters Into Option to Acquire Cypris Medical

Following the completion of a clinical trial to be initiated in 2021, Allergan Aesthetics will have the right to exercise an option to acquire Cypris Medical, including the company’s Xact device. The planned clinical trial will evaluate the safety and effectiveness of Xact in minimally invasive mid-face and neck lift procedures.

Stay informed.

Sign up for our newsletter and we’ll email you when we have updates.